Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yao-Yu Hsieh

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Diagnostics (Basel, Switzerland)|February 13, 2025
Correction: Ong et al. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. <i>Diagnostics</i> 2023, <i>13</i>, 2296Khaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, et al.
International Journal of Molecular Sciences|May 11, 2019
HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 CellsShu-Huey Chen, Jyh-Ming Chow, Yao-Yu Hsieh, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic BiomarkerKhaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, et al.
Journal of Surgical Oncology|January 18, 2011
Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcomaHao-Wei Teng, Hsei-Wei Wang, Wei-Ming Chen, et al.
International Journal of Colorectal Disease|June 25, 2010
Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastasesJin-Hwang Liu, Yao-Yu Hsieh, Wei-Shone Chen, et al.
Cancers|June 4, 2020
<i>ABL</i> Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In VivoShu-Huey Chen, Yao-Yu Hsieh, Huey-En Tzeng, et al.
Journal of the Chinese Medical Association : JCMA|May 31, 2011
Effective salvage therapy of imatinib-resistant gastrointestinal stromal tumor with combination of imatinib and pegylated liposomal doxorubicinYao-Yu Hsieh, Chueh-Chuan Yen, Chun-Nan Yeh, et al.
Frontiers in Oncology|October 7, 2024
Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle EastSuyog Jain, Shaheenah Dawood, Viraj Lavingia, et al.
Liver Cancer|June 13, 2025
Predicting Survival Outcomes in Patients with Hepatocellular Carcinoma Receiving Lenvatinib by Using the Up7-ALBI ScoreChien-Hung Lu, Wei-Yu Kao, Chih-Horng Wu, et al.
Oncotarget|July 9, 2014
Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistanceMan Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Diagnostics (Basel, Switzerland)|February 13, 2025
Correction: Ong et al. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. <i>Diagnostics</i> 2023, <i>13</i>, 2296Khaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, et al.
International Journal of Molecular Sciences|May 11, 2019
HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 CellsShu-Huey Chen, Jyh-Ming Chow, Yao-Yu Hsieh, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic BiomarkerKhaa Hoo Ong, Yao-Yu Hsieh, Ding-Ping Sun, et al.
Journal of Surgical Oncology|January 18, 2011
Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcomaHao-Wei Teng, Hsei-Wei Wang, Wei-Ming Chen, et al.
International Journal of Colorectal Disease|June 25, 2010
Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastasesJin-Hwang Liu, Yao-Yu Hsieh, Wei-Shone Chen, et al.
Cancers|June 4, 2020
<i>ABL</i> Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In VivoShu-Huey Chen, Yao-Yu Hsieh, Huey-En Tzeng, et al.
Journal of the Chinese Medical Association : JCMA|May 31, 2011
Effective salvage therapy of imatinib-resistant gastrointestinal stromal tumor with combination of imatinib and pegylated liposomal doxorubicinYao-Yu Hsieh, Chueh-Chuan Yen, Chun-Nan Yeh, et al.
Frontiers in Oncology|October 7, 2024
Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle EastSuyog Jain, Shaheenah Dawood, Viraj Lavingia, et al.
Liver Cancer|June 13, 2025
Predicting Survival Outcomes in Patients with Hepatocellular Carcinoma Receiving Lenvatinib by Using the Up7-ALBI ScoreChien-Hung Lu, Wei-Yu Kao, Chih-Horng Wu, et al.
Oncotarget|July 9, 2014
Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistanceMan Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, et al.
Pageof 5